JP2024522820A5 - - Google Patents

Info

Publication number
JP2024522820A5
JP2024522820A5 JP2023578189A JP2023578189A JP2024522820A5 JP 2024522820 A5 JP2024522820 A5 JP 2024522820A5 JP 2023578189 A JP2023578189 A JP 2023578189A JP 2023578189 A JP2023578189 A JP 2023578189A JP 2024522820 A5 JP2024522820 A5 JP 2024522820A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
tqs
composition according
administered
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522820A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/034012 external-priority patent/WO2022266455A1/en
Publication of JP2024522820A publication Critical patent/JP2024522820A/ja
Publication of JP2024522820A5 publication Critical patent/JP2024522820A5/ja
Pending legal-status Critical Current

Links

JP2023578189A 2021-06-17 2022-06-17 2-アリールベンゾイミダゾールの治療上有効な経口投与 Pending JP2024522820A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163211636P 2021-06-17 2021-06-17
US63/211,636 2021-06-17
US202263300551P 2022-01-18 2022-01-18
US63/300,551 2022-01-18
PCT/US2022/034012 WO2022266455A1 (en) 2021-06-17 2022-06-17 Therapeutically effective oral administration of a 2 arylbenzimidazole

Publications (2)

Publication Number Publication Date
JP2024522820A JP2024522820A (ja) 2024-06-21
JP2024522820A5 true JP2024522820A5 (cg-RX-API-DMAC7.html) 2025-06-25

Family

ID=84527631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578189A Pending JP2024522820A (ja) 2021-06-17 2022-06-17 2-アリールベンゾイミダゾールの治療上有効な経口投与

Country Status (4)

Country Link
US (2) US20240307356A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355326A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024522820A (cg-RX-API-DMAC7.html)
WO (1) WO2022266455A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202416960A (zh) * 2022-06-17 2024-05-01 美商特朗奎斯治療股份有限公司 2-芳基苯并咪唑化合物之調配物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016061190A1 (en) * 2014-10-14 2016-04-21 The Board Of Trustees Of The Leland Stanford Junior University Method for treating neurodegenerative diseases
ES2830447T3 (es) * 2015-12-15 2021-06-03 Univ Leland Stanford Junior Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación
US20240316008A1 (en) * 2020-06-22 2024-09-26 Tranquis Therapeutics, Inc. Treatment of systemic immune activation syndromes

Similar Documents

Publication Publication Date Title
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
AU2009227629B2 (en) Dosing regimen for a selective S1P1 receptor agonist
JP7006990B2 (ja) 眼障害の処置のための組成物及び方法
JP2013014629A (ja) R(+)プラミペキソールを用いた神経回復
JP2022544711A5 (cg-RX-API-DMAC7.html)
JP6837486B2 (ja) 加齢に関連する認知障害及び神経炎症を予防及び/又は治療する方法
JP2026035701A5 (cg-RX-API-DMAC7.html)
JP2023552700A5 (cg-RX-API-DMAC7.html)
JP2022514537A5 (cg-RX-API-DMAC7.html)
JP2025157438A5 (cg-RX-API-DMAC7.html)
JPH0761923A (ja) アルツハイマー病治療剤
JP2022500485A5 (cg-RX-API-DMAC7.html)
JP2023548429A5 (cg-RX-API-DMAC7.html)
JP2023518640A5 (cg-RX-API-DMAC7.html)
EP1154766B1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln, zur behandlung von erkrankungen bei mensch und tier, welche durch die hemmung der aktivierung von nf-kappa b therapeutisch beeinflusst werden können
JP2024545496A5 (cg-RX-API-DMAC7.html)
DE60125062T2 (de) Quetiapin zur Behandlung der Dyskinesie in nicht-psychotischen Patienten
JP2021530568A5 (cg-RX-API-DMAC7.html)
US20170112804A1 (en) Lipoic acid and derivatives thereof for the treatment of cystinuria
CN1290166A (zh) 运动障碍的治疗
JP2022550458A5 (cg-RX-API-DMAC7.html)
JP3002766B2 (ja) 脳浮腫治療剤
JP6188784B2 (ja) 炎症性および免疫性疾患の治療のための組成物
JP2024541770A5 (cg-RX-API-DMAC7.html)
WO2004096230A1 (ja) 関節リウマチ治療剤